# Ibuprofen Versus Ibuprofen Plus Caffeine in the Treatment of Migraine.

> **NCT01426971** · PHASE3 · WITHDRAWN · sponsor: **Sanofi**

## Conditions studied

- Pain

## Interventions

- **DRUG:** IBUPROFEN + CAFFEINE
- **DRUG:** IBUPROFEN

## Key facts

- **NCT ID:** NCT01426971
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2012-12
- **Primary completion:** 2013-06
- **Final completion:** 2013-06
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2012-11-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01426971

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01426971, "Ibuprofen Versus Ibuprofen Plus Caffeine in the Treatment of Migraine.". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01426971. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*